<DOC>
	<DOCNO>NCT01323218</DOCNO>
	<brief_summary>Obstructive sleep apnea/hypopnea syndrome ( OSAHS ) highly prevalent disorder multiple comorbidities . OSAHS characterize repetitive episode airflow reduction ( hypopnoea ) cessation ( apnoea ) due upper airway collapse sleep . Its major risk factor obesity . However , pathogenesis complex multifactorial . Reduced upper airway muscle tonus and/or unstable neuromuscular output seem involve collapsus . A normal vitamin D status necessary normal muscle function neuromuscular output . As obesity associate high rate hypovitaminosis D , appear interest evaluate effect vitamin D supplementation OSAHS patient vitamin D deficiency .</brief_summary>
	<brief_title>Sleep Apnea Syndrome Vitamin D</brief_title>
	<detailed_description>Prospective , longitudinal , double bind , randomize study effect vitamin D supplementation OSAHS patient hypovitaminosis D. After write informed consent , patient randomize receive single dose oral vitamin D ( 400 000 UI ) placebo . Subjects undergo medical screen randomisation placebo active group . Follow-up measurement perform begin ( day 0 ) 32 day vitamin D supplementation : clinical examination , biological check sleep parameter evaluation . Patients instruct stop use continuous positive airway pressure device two night nocturnal sleep study .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Moderate severe obstructive sleep apnoea ( AHI &gt; 15 ) With without continuous positive airway pressure minimum six month age 3075 year Vitamin D2D3 level &lt; 30 ng/ml Diseases therapy know interfere phosphocalcium vitamin D metabolism Patients mixed sleep apnoea ( central obstructive ) Patients CPAP use &lt; 4 hour per night Patients maxillofacial oropharyngeal disease ) Patients chronic respiratory failure , hypercapnic patient Muscle diseases Alcohol intake &gt; 2 glass per day Body mass index &gt; 40 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Obstructive sleep apnea-hypopnea syndrome</keyword>
	<keyword>OSAHS</keyword>
	<keyword>Vitamin D</keyword>
</DOC>